3 0 3 1
decreases over time, suggesting that the transduction of the Shh signal is reduced as the neural 1 0 1 development proceeds [17] . Importantly, this adaptation takes place only in the context of the neural 1 0 2 differentiation, and not in cultured cells, such as NIH3T3 fibroblast cells [1, 17, 18] , suggesting that 1 0 3
some key genes are specifically induced in a developmental context. However, such regulators have 1 0 4 yet to be identified.
0 5
In parallel with Shh activity, intracellular cyclic AMP (cAMP) level and the activity of the 1 0 6 downstream mediator PKA have critical roles for the neural tube pattern formation [5, 19] . Absence of 1 0 7
PKA activity affects the subcellular localisation and processing of Gli proteins at the cellular level, 1 0 8
and results in the expansion of the ventral domains of the neural tube [5] . Likewise, the activity of 1 0 9 adenylyl cyclase 5 and 6 (AC5 and AC6, respectively), which encourage the production of cAMP by 1 1 0 resolving adenosine triphosphate (ATP), affects the Gli activity and determination of the ventral cell 1 1 1 fate [20, 21] . Moreover, G-protein coupled receptors (GPCRs) have been suggested to control the 1 1 2 neural tube pattern formation through regulating the intracellular cAMP level [18, 22] . GPCRs couple 1 1 3
with G-proteins that are comprised of Gα, Gβ and Gγ subunits. G-proteins are categorised into several 1 1 4
subclasses based on the type of the Gα protein; Gα s and Gα q can potentiate the cAMP level, whereas 1 1 5
Gα i decreases this level [23] . With respect to the neural tube development and Shh signal, GPR161 1 1 6
has been suggested to interact with Gα s and negatively regulates the ventral neural identities by 1 1 7
elevating the cAMP level [24] . Conversely, GPR175 interacts with Gα i protein and enhances the Shh 1 1 8 signal [25] . Therefore, the GPCR/cAMP/PKA axis is a critical regulatory pathway in the neural tube 1 1 9 pattern formation. However, the mechanisms by which cAMP/PKA activity is involved in the 1 2 0 temporal changes of Gli activity remain to be revealed.
2 1
In this study, we hypothesised the existence of a GPCR regulated by the Shh signal. To 1 2 2 1 4 0 GPR17 expression was found in a wide area in the ventral at the beginning of the neural tube 1 4 1 development (Fig 1A) , the floor plate expression was abolished as development progressed (Fig 1B   1 4 2 and 1C). In addition, while the expression of GPR17 occurred in a wide area in the ventral region at 1 4 3 the beginning of the neural tube development (Fig 1A) , the floor plate expression halted as 1 4 4 development progressed ( Fig 1B and 1C ).
4 5
To investigate the relationship between Shh and GPR17 expression, we performed an ex vivo 1 5 0 hours up to 48 hours ( Fig 1D) . At 12 hours, GPR17 expression was higher in explants treated with 1 5 1 Shh L or Shh H than in untreated explants ( Fig 1D) , and this trend continued at 24 and 36 hours. By 1 5 2 contrast, at 48 hours, expression was downregulated in explants treated with Shh H , but remained high 1 5 3 in explants treated with Shh L . This finding is consistent with the in vivo expression pattern of 1 5 4
abolished expression in the floor plate ( Fig 1A) .
1 5 5
Next we explored the upstream transcription factors that induce GPR17 expression. Since
5 8
This effect occurred independently from the programmed cell death, as the increasing number of 
6 0
To confirm that Shh activity was decreased by GPR17-mediated signalling, we performed a 2 6 1 reporter assay to measure Gli activity. We prepared pools of explants transfected with the GBS-Luc 2 6 2 reporter construct, which harboured the luciferase gene driven by the Gli binding sequence (GBS).
6 3
The luciferase activity was measured after 24 hours. As the result, Gli activity was significantly 2 6 4 upregulated by Shh H (Fig 3L lanes 1 and 2) . However, when MDL29951 was added along with Shh H , 2 6 5 the activity was reduced to a level close to that of explants cultured with the Shh L (more than four 2 6 6 pools of explants in each condition; Fig 3L lanes 2-4) . These data confirmed that the Gli activity was 2 6 7 perturbed by GPR17 and its related signals.
6 8
We attempted to further investigate if the activation of the GPR17-related signal correlated 2 6 9
with the elevation of the intracellular cAMP level, by assaying intermediate neural explants.
7 0
Consistent with the previous observation, the cAMP level in the explants treated with Shh for 24 hours 2 7 1 showed a lower cAMP level than in the control explants ( Fig 3M, lanes 1 and 2) in the cAMP level.
7 5
Together, these findings suggested that the GPR17-mediated signalling pathway negatively 2 7 6
regulates Shh activity in the context of neural tube pattern formation through the upregulation of the 2 7 7 intracellular cAMP level. To further investigate the functions of GPR17 in the development of neural tube pattern 2 8 1 formation, we employed a loss-of-function approach. For this purpose, we designed a siRNA and a 2 8 2
shRNA targeting GPR17 (si-GPR17 and sh-GPR17), and carried out in ovo electroporation into the 2 8 3 neural tube.
8 4
We first electroporated si-GPR17 into neural tubes at HH stage 11. At 48 hpt, we observed Given that expression of GPR17 is induced by Shh, and GPR17 negatively regulates the Shh 3 0 3 signal activity at the intracellular level ( Fig 1B, 1D , 2E, 3E-3L), we reasoned that GPR17 is involved 3 0 4
in temporal regulation of Gli activity [13] [14] [15] . To test this hypothesis, we analysed the role of GPR17 3 0 5
in temporal regulation of the Gli activity.
0 6
First, to confirm that the intracellular Shh signal activity was aberrantly upregulated, we 3 0 7 prepared intermediate neural explants electroporated with si-GPR17, and then treated them with Shh L .
0 8
Although Olig2-expressing cells were predominant in the si-control electroporated explants (5 areas; 
1 6
We next sought to analyse dynamic control of the intracellular Shh signal activity during 3 1 7 ventral neural differentiation. For this purpose, we performed luciferase reporter assays using GBS-3 1 8
Luc at various time points. We prepared explants electroporated with GBS-Luc with either si-control 3 1 9
or si-GPR17, and then measured Gli activity at a series of time points from 6 to 48 hours after the 3 2 0 initiation of the culture. In si-control-electroporated explants treated with Shh L , Shh activity gradually 3 2 1 decreased over time, peaking at 6 hours and becoming undetectable by the 48 hour time point (more 3 2 2 than 3 explants per point; Fig 5J, blue line) , consistent with previous reports [13, 14] . On the other 3 2 3
hand, in explants with si-GPR17, Gli activity at 6 hours was comparable to that of the si-control 3 2 4
explants, but the activity was significantly higher at 24 hours and still detectable at 36 hours ( Fig 5J, 3 2 5 red line).
2 6
We next attempted to confirm that the dynamic Gli activity reflects the gene expression. As 3 2 7
the Ptch1 and Gli1 genes are direct targets of the Shh signal, their expression levels correspond to the 3 2 8
Gli activity [17] . We therefore cultured the explants electroporated with si-control or si-GPR17 in the 3 2 9 presence of Shh L for different time periods, and measured the expression levels of Ptch1 and Gli1 by 3 3 0
RT-qPCR. As the result, the expression peaked at 12 hours and then decreased quickly at 24 hours in 3 3 1 si-control electroporated explants ( Fig 5K and S6H Fig, blue lines) . However, in the si-GPR17-3 3 2 electroporated explants, while the expression peak at 12 hours was comparable, the decrease was 3 3 3 delayed, and the expression level was significantly higher at 24 hours ( Fig 5K and S6H Fig, red lines) .
4
This result supports the idea that the dynamic Gli activity was affected, at least partially, by the 3 3 5
perturbation of the GPR17 expression.
6
In addition, we calculated the ratio of Gli3FL and Gli3R in the neural tube. For this purpose, 3 3 7
we prepared isolated neural tubes that had been electroporated with either si-control or si-GPR17, and 3 3 8
analysed the forms of Gli3 by western blotting. We found that the ratio of Gli3FL over Gli3R was 
4 1
Together, these findings indicate that GPR17 is an essential upstream factor that controls the We finally assessed whether GPR17 functions are conserved in different organisms by 3 4 7
investigating its expression and functions in aspects of mouse development.
4 8
We first analysed the expression pattern of GPR17 in the mouse spinal cord. At embryonic 3 4 9 day 10.5 (e10.5) when neural tube pattern formation is taking place, expression was evident in the 3 6 0
First, we evaluated GPR17 expression by RT-qPCR in each neural subtype. The results 3 6 1 revealed significantly higher GPR17 expression in pMN and p3 cells than in FP 5 days after the start 3 6 2 of differentiation (day 5) (3 experiments; Fig 6A) , suggesting that expression can be recapitulated in 3 6 3 neural cells differentiated from ES cells.
6 4
Next, we sought to analyse the function of GPR17 in neural differentiation and subtype 
7 5
We next verified this tendency by RT-qPCR. In cells treated with si-GPR17s, the Nkx2.2 3 7 6 expression was higher than in si-control-transfected cells at day 5, confirming the results obtained by 3 7 7 the immunohistochemistry (3 experiments; Fig 6L) . Furthermore, the expression level of Ptch1, a In this study, we isolated one of the GPCRs GPR17, and characterised its role in neural 3 8 7 development. Although its expression is induced by Shh, GPR17 negatively regulates the Shh signal, 3 8 8 thereby affecting the dynamicity of the Gli activity [13, 14] . Negative regulation of the intracellular 3 8 9
Shh signal by GPR17 is conserved in the mouse, as demonstrated by a system involving neural 3 9 0 differentiation of ES cells (Fig 6) .
9 1
GPR17 was initially recognised as one of the genes that respond to neural tube injury, brain 3 9 2 damage or pathological situations [42] [43] [44] . To reveal the essential roles of GPR17 in the body, GPR17-3 9 3
knockout mice were generated. The analysis consequently elucidated that GPR17 is a molecular timer 3 9 4
for oligodendrocyte differentiation [44] ; the deficiency of GPR17-gene caused the earlier 3 9 5 differentiation and excessive production of oligodendrocyte cells [27] . Subsequently, the function in 3 9 6
the oligodendrocyte development and the demyelination and remyelination have been emphasised.
9 7
GPR17 expression is gradually upregulated during the demyelination induced by the glial toxin 3 9 8
Lysolecithin [45] . Conversely, the antagonist supporting GPR17 increases the oligodendrocyte cell 
0 5
Although GPR17 has been suggested to be a receptor for the uracil nucleotides and Cysteinyl 4 0 6 leukotrienes (cysLTs) [42, 48] , the actual ligand(s) for GPR17 working in the developmental contexts 4 0 7
have not been identified. In this study, while we did not find an explicit effect of the overexpression of 
1 1
In this study, we utilised MDL29951 to experimentally activate GPR17 (Fig 3F, 3H, 3J 
1 8
In the chick embryos, our in situ hybridisation analysis detected the expression of GPR17 at 4 1 9 the earlier stages than the onset of gliogenesis, which contributed to neural tube pattern formation (Fig   4  2  0 1A, 1B, 1D). Also in the mouse embryos, the immunohistochemistry analysis revealed the GPR17 4 2 1 expression at e10.5 at the ventral region of the spinal cord (S7A Fig). By contrast, in a previous report 4 2 2
[27], GPR17 expression is firstly recognised at e14.5 in the mouse brain using reporter gene 4 2 3 expression. The difference between our data and the previous findings is presumably caused by the 4 2 4 protein stability of GPR17 or the difference in the detection methods.
2 5
While our analysis revealed the essential roles of GPR17 on the dorsal-ventral pattern 4 2 6
formation of the spinal cord in chick, the effect in the mouse neural tube has been unknown, and at 4 2 7 least, does not seem to be critical [27, 45, 46] , as GPR17-deficient mice are viable. This is probably due 4 2 8
to the redundant roles of the multiple GPCRs expressed in the neural tube. The expression of Adenylyl 4 2 9
cyclase 5 (AC5), which catalases the dissociation of ATP to make cAMP [20, 21] , was found to be GPCRs may differ among different species; the chick neural tube mainly depends on GPR17 in the 4 3 3 pattern formation while the mice depend also on the other genes.
3 4
GPCRs can bind to different types of Gα proteins, including Gα i , Gα s , Gα q and Gα 12,13 [23].
3 5
Among these Gα proteins, Gα q and Gα s can increase the intracellular cAMP level, whereas Gα i 4 3 6
proteins mostly exert an inhibitory effect, and GPR17 can bind all types of G-proteins [35] . During the 4 3 7 remyelination, GPR17 binds to Gα i and decreases the cAMP level [28, 36, 51, 52] . By contrast, in our 4 3 8 experiments GPR17 rather upregulated the cAMP level, presumably by binding to Gα q and/or Gα s , 4 3 9
suggesting that it has diverse and cell type-specific functions.
0
Concerning the relationships between GPCR and Shh signal, two GPCRs, GPR161 and 4 4 1 GPR175, have been well characterised [22, 24, 25] . GPR161 is an orphan receptor that increases the 4 4 2 intracellular cAMP level and has a negative effect on the ventral neural pattern formation. Within the 4 4 3 cell, GPR161 is localised at the ciliary shaft and is involved in local calcium uptake when Shh protein 4 4 4
arrives at the cilia [21, 24] . GPR175, which localises to non-ciliary cell membrane, is translocated to 4 4 5 the cilia when cells are exposed to Shh [25] . By contrast, GPR17 is localised throughout in the cells 4 4 6 ( Fig 2B) , and its localisation is not affected by Shh signals (Fig 2B-2D' ), suggesting that the roles of 
6 2
Although Shh induces the GPR17 expression ( Fig 1D) , GPR17 does not seem to be a direct this finding, overexpression of Olig2 in neural explants induces GPR17 expression ( Fig 1E) domains where Olig2 is not expressed (Fig 1B) , and the overexpression of Olig2 DBD -VP16 only 4 7 6
partially block the GPR17 expression (S10B Fig). 
7 7
In a developmental context, negative feedback regulation confers diversity of cell types and 4 7 8
robustness of pattern formation [14] . To date, multiple negative feedback systems for the Gli activity 4 7 9
have been identified [17] . For instance, the Ptch1 gene, whose product negatively regulates the 4 8 0
intracellular Shh signal activity, is a direct target of Shh (Fig 7) [13]. Moreover, expression of the GPCRs that can couple with Gα q or Gα s were identified by referring to the website 4 9 7
(http://gpcrdb.org), and qPCR primers were designed against the corresponding genes (S1 Table) .
9 8
Relative expression levels were analysed by RT-qPCR in neural explants treated or untreated with 4 9 9
Shh H (S1 Fig) . NCBI Gene IDs for chicken and mouse GPR17 are 769024 and 574402, respectively. protein VP16, as described previously [55] . Embryos were fixed with 4% paraformaldehyde, 5 1 3 subsequently incubated with 15% sucrose for cryoprotection and embedded in 7.5% gelatine (Sigma).
1 4
Cryosections were cut at 14 μm increments and analysed with immunohistochemistry or in situ 5 1 5
hybridisation. The sections from at least five independent embryos were analysed, and the number of 5 1 6 the embryos analysed were indicated in the text. For loss-of-function experiments, si-GPR17 5 1 7
(GGAACAGAGUGGAGAAACACCUG(dA)(dA) (sense) and 5 1 8 UUCAGGUGUUUCUCCACUCUGUUCCCA (antisense)) or si-Luciferase 5 1 9
(ACUGAGACUACAUCAGCUAUUCU(dG)(dA) (sense) and 5 2 0 UCAGAAUAGCUGAUGUAGUCUCAGUGA (antisense), as a negative control; Eurofin) was 5 2 1 electroporated with the pCIG vector, which encodes GFP as a tracer. For gene silencing with short-5 2 2 hairpin constructs, AAGAGACACACCTCGAGAATG (chicken GPR17) or
